Creatine monohydrate does not increase strength in patients with hereditary neuropathy
The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
Creatine is a guanidino compound produced endogenously by the liver and consumed in diets inclusive of meat and fish. Creatine monohydrate (CM) supplementation increases lean body mass, high-intensity power output, and strength in young healthy volunteers.1 Clinical trials of CM supplementation have demonstrated modest improvements in muscular strength, endurance, and activities of daily living (ADL) for patients with neuromuscular disorders.2-4⇓⇓ We evaluated the potential benefits of short-term CM supplementation for patients with hereditary motor sensory neuropathy (HMSN) type I and II. ### Subjects. Thirty-nine subjects (mean age 42.5 years) with HMSN types I (n = 34) and II (n = 5) gave their informed consent to take part. The diagnosis of HMSN I or II was confirmed from the clinical presentation, family history, as well as confirmatory genetic or electrophysiologic assessment. ### Study design. A double-blinded, placebo-controlled, crossover design was used. Subjects were randomized to CM or placebo for 1 month, followed by a 5-week washout period. They then …
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Elevation of creatine in resting and exercised muscle of normal subjects by creatine supplementation
Harris, R. C., Söderlund, K., & Hultman, E. (1992) · Clinical Science · doi:10.1042/cs0830367 · Cited by 1,168
Cited by
Pharmacokinetics of the Dietary Supplement Creatine
Persky, A. M., Brazeau, G. A., & Hochhaus, G. (2003) · Clinical Pharmacokinetics · doi:10.2165/00003088-200342060-00005 · Cited by 132
Clinical Use of Creatine in Neuromuscular and Neurometabolic Disorders
Tarnopolsky, M. A. (2007) · Subcellular Biochemistry · doi:10.1007/978-1-4020-6486-9_10 · Cited by 67
“Our group evaluated a total of 39 participants with confirmed CMT disease type 1 (N = 34) and type 2 (N = 5) (Doherty et al., 2001).”
BackgroundMethodSelf-citation
Metadata
- Authors
- Doherty, T. J., Lougheed, K., Markez, J., & Tarnopolsky, M. A.
- Venue
- Neurology
- Published
- 2001-08-14
- Volume
- 57
- Issue
- 3
- Pages
- 559-560
- ISSN
- 0028-3878 (ISSN-L)
- 1526-632X
- OpenAlex
- W2036533303
- Cited by
- 16
- References
- 1
- FWCI
- 0.93
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Creatine monohydrate does not increase strength in patients with hereditary neuropathy. https://app.cochat.ai/papers/10.1212/wnl.57.3.559
- The paper
- Doherty, T. J., Lougheed, K., Markez, J., & Tarnopolsky, M. A. (2001). Creatine monohydrate does not increase strength in patients with hereditary neuropathy. Neurology. https://doi.org/10.1212/wnl.57.3.559
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.